Tag:

imaging biomarkers

Latest Headlines

Latest Headlines

GE wins FDA approval for a second Alzheimer's imaging agent

The FDA has approved the second imaging agent that can be used to detect a toxic protein found clustered in the fogged brains of Alzheimer's patients, but there's no guarantee it will ever find much of a market.

GE wins FDA approval for a second Alzheimer's imaging agent

The FDA has approved the second imaging agent that can be used to detect a toxic protein found clustered in the fogged brains of Alzheimer's patients, but there's no guarantee it will ever find much of a market.

Medicare's rejection of Alzheimer's test leaves Lilly in the lurch

The regulators in charge of Medicare recently dealt Eli Lilly a setback when they adamantly refused to reimburse for the Alzheimer's imaging agent Amyvid in all but a handful of cases.

Medicare's rejection of Alzheimer's test leaves Lilly in the lurch

The regulators in charge of Medicare recently dealt Eli Lilly a setback when they adamantly refused to reimburse for the Alzheimer's imaging agent Amyvid in all but a handful of cases.

NIH pours $900K into Parkinson's biomarker research

NIH is looping Emory's Rollins School of Public Health into its Parkinson's Disease Biomarker Program, pledging $900,000 to a research team aiming to discover new ways of identifying the ailment.

NIH pours $900K into Parkinson's biomarker research

NIH is looping Emory's Rollins School of Public Health into its Parkinson's Disease Biomarker Program, pledging $900,000 to a research team aiming to discover new ways of identifying the ailment.

Brain biomarker may help open door to personalized depression drugs

A group of investigators at the NIH say that they've found a neuroimaging biomarker at the back of the brain that could prove effective in personalizing drugs in the future--raising the odds of matching a patient with the best therapy.

Brain biomarker may help open door to personalized depression drugs

A group of investigators at the NIH say that they've found a neuroimaging biomarker at the back of the brain that could prove effective in personalizing drugs in the future--raising the odds of matching a patient with the best therapy.

Biomarkers could tag chemo heart risk

A combination of biomarkers and imaging could tag chemotherapy-induced heart damage early on, cutting long-term heart risk in cancer survivors, according to a study reported at the recent San Antonio Breast Cancer Symposium.

Biomarkers could tag chemo heart risk

A combination of biomarkers and imaging could tag chemotherapy-induced heart damage early on, cutting long-term heart risk in cancer survivors, according to a study reported at the recent San Antonio Breast Cancer Symposium.